Resources

Defining a patient strategy for emerging markets

Consulting

What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?

Specialized “premium” therapy sales in growth markets is a strategic focus in the industry, and patient services offerings play an increasing role in achieving this goal. The development of patient programs in developing countries requires calibration to nuances of the local context, particularly for out-of-pocket markets.

What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?

This white paper has been written by our consultants.

Find out actionable insights by downloading the complete white paper:

Defining a patient strategy for emerging markets

What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?

See also

Observia co-construit une formation sur les programmes patient avec l'IFIS

From Real-World Data to Real-World Evidence: why and how

Scalability, the one way to multiply an e-health solution's impact

Defining a patient strategy for emerging markets

What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?

Share

See also

Observia co-construit une formation sur les programmes patient avec l'IFIS

From Real-World Data to Real-World Evidence: why and how

Scalability, the one way to multiply an e-health solution's impact